Apoptosis: Basic concepts and potential significance in human cancer

Archives of Pathology and Laboratory Medicine

Volumn 122, Issue 4, 1998, Pages 310-319

  Staunton, Marie J ^a,b   Gaffney, Eoin F ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; CARCINOGENESIS; CELL DEATH; ELECTRON MICROSCOPY; ENZYME REGULATION; FLOW CYTOMETRY; GENE CONTROL; HUMAN; ONCOGENE; ONCOGENE C MYC; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

APOPTOSIS; GENES, TUMOR SUPPRESSOR; HUMANS; MICROSCOPY, ELECTRON; NEOPLASMS; ONCOGENES;

EID: 0031893331     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (155)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-257.
2. Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev. 1992;11:95-103.
3. Ellis HM, Yuan JY, Horvitz HR. Mechanisms and functions of cell death. Ann Rev Cell Biol. 1991;7:663-698.
4. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251-253.
5. MacDonald HR, Lees RK. Programmed death of autoreactive thymocytes. Nature. 1990;343:642-644.
6. Ameisen JC. Programmed cell death and AIDS: from hypothesis to experiment. Immunol Today. 1992;13:388-391.
7. Kerr JFR. Shrinkage necrosis: a distinct mode of cell death. J Pathol. 1971; 105:13-20.
8. Weedon D, Searle J, Kerr JFR. Apoptosis: its nature and implications for dermatopathology. Am J Dermatopathol. 1979;1:133-144.
9. Solary E, Dubrez L, Eymin B. The role of apoptosis in the pathogenesis and treatment of disease. Eur Respir J. 1996;9:1293-1305.
10. Laine J, Etelamaki P, Holmberg C, Dunkel L. Apoptotic cell death in human chronic renal allograft rejection. Transplantation. 1997;63:101-105.
11. Meyn RE, Stephens LC, Milas L. Programmed cell death and radioresistance. Cancer Metastasis Rev. 1996;15:119-131.
12. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell. 1994; 78:539-542.
13. Desmouliere A, Badid C, Bochaton-Piallat M-L, Gabbiani G. Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int J Biochem Cell Biol. 1997;29:19-30.
14. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1980;284:555-556.
15. McConkey DJ, Orrenius S. Signal transduction pathways in apoptosis. Stem Cells (Dayt). 1996;14:619-631.
16. Eastman A. Apoptosis: a product of programmed and unprogrammed cell death. Toxicol Appl Pharmacol. 1993;121:160-164.
17. Orrenius S. Apoptosis: molecular mechanisms and implications for human disease. J Int Med. 1995;237:529-536.
18. Walker PR, Weaver VM, Lach B, LeBlanc J, Sikorska M. Endonuclease activities associated with high molecular weight and internucleosomal DNA fragmentation in apoptosis. Exp Cell Res. 1994;213:100-106.
19. Arends MJ, Morris RC, Wyllie AH. Apoptosis, the role of the endonuclease. Am J Pathol. 1990;136:593-608.
20. Dini L, Coppola S, Ruzittu MT, Ghibelli L. Multiple pathways for apoptotic nuclear fragmentation. Exp Cell Res. 1996;223:340-347.
21. Watanabe H, Kanbe K, Shinozaki T, Hoshino H, Chigira M. Apoptosis of a fibrosarcoma induced by protein-free culture involves DNA cleavage to large fragments but not internucleosomal fragmentation. Int J Cancer. 1995;62:191-198.
22. Oberhammer FA, Hochegger K, Froschl C, Tiefenbacher R, Pavelka M. Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B without enhanced activation of cdc2 kinase. J Cell Biol. 1994;136:827-837.
23. Cohen GM, Sun XM, Snowden RT, Dinsdale D, Skiletter DN. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J. 1992;286:331-334.
24. Zakeri ZF, Quaglino D, Latham T, Lockshin RA. Delayed internucleosomal DNA fragmentation in programmed cell death. FASEB J. 1993;7:470-478.
25. Melino G, Annicchiarico-Petruzzelli M, Piredda L, et al. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol Cell Biol. 1994;14:6584-6596.
26. Fesus L, Davies PJA, Piacentini M. Apoptosis: molecular mechanisms in programmed cell death. Eur J Cell Biol. 1991;56:170-177.
27. Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today. 1993;14:131-136.
28. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992;148:2207-2216.
29. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods. 1995; 184:39-51.
30. Clarke PGH, Clarke S. Nineteenth century research on naturally occurring cell death and related phenomena. Anat Embryol. 1996;193:81-99.
31. Majno G, Joris I. Apoptosis, oncosis and necrosis: an overview of cell death. Am J Pathol. 1995;146:3-15.
32. Sarraf CE, Bowen ID. Proportions of mitotic and apoptotic cells in a range of untreated experimental tumours. Cell Tissue Kinetics. 1988;21:45-49.
33. Hollowood K, McCartney JC. Reduced apoptotic cell death in follicular lymphoma. J Pathol. 1991;163:337-342.
34. Leoncini L, Del Vecchio MT, Megha T, et al. Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol. 1993;142:755-763.
35. Alison M, Sarraf C. Understanding Cancer: From Basic Science to Clinical Practice. Cambridge, UK: Cambridge University Press; 1997:133-193.
36. Staunton MJ, Gaffney EF. Tumor type is a determinant of susceptibility to apoptosis. Am J Clin Pathol. 1995;103:300-307.
37. Kong J, Ringer DP. Quantative in situ image analysis of apoptosis in well and poorly differentiated tumors from rat liver. Am J Pathol. 1995;147:1626-1632.
38. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in-situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
39. Mundle SD, Gao XZ, Khan S, Gregory SA, Preisler HD, Raza A. Two in situ labeling techniques reveal different patterns of DNA fragmentation during spontaneous apoptosis in vivo and induced apoptosis in vitro. Anticancer Res. 1995;15:1895-1904.
40. Wijsman JH, Jonker RR, Keijzer R, van de Velde CJH, Cornelisse CJ, Van Dierendonck JH. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem. 1993;41:7-12.
41. Ansari B, Coates PJ, Greenstein BD, Hall PA. In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol. 1993;170:1-8.
42. Gaffney EF, O Neill AJ, Staunton MJ. In situ end-labelling, light microscopic assessment and ultrastructure of apoptosis in lung carcinoma. J Clin Pathol. 1995;48:1017-1021.
43. Todd D, Yang G, Brown RW, et al. Apoptosis in renal cell carcinoma: detection by in situ end-labeling of fragmented DNA and correlation with other prognostic factors. Hum Pathol. 1996;27:1012-1017.
44. Drachenberg C, Ioffe O, Papadimitriou JC. Progressive increase of apoptosis in prostatic intraepithelial neoplasia and carcinoma: comparison between in situ end-labeling of fragmented DNA and detection by routine hematoxylineosin staining. Arch Pathol Lab Med. 1997;121:54-58.
45. Sasano H. In situ end labeling and its applications to the study of endocrine disease: how can we study programmed cell death in surgical pathology materials? Endocrine Pathol. 1995;6:87-89.
46. Davison FD, Groves M, Scaravilli F. The effects of formalin fixation on the detection of apoptosis in human brain by in situ end-labelling of DNA. Histochem J. 1995;27:983-988.
47. Bardales RH, Xie SS, Hsu SM. In situ DNA fragmentation assay for detection of apoptosis in paraffin-embedded tissue sections - technical considerations. Am J Clin Pathol. 1997;107:332-336.
48. Potten CS. What is an apoptotic index measuring? A commentary. Br J Cancer. 1996;74:1743-1748.
49. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry. 1997;27:1-27.
50. Evan G, Wyllie A, Gilbert C, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992;69:119-128.
51. Pulkkinen JO, Elomaa L, Joensuu H, Martikkainen P, Servomaa K, Grenman R. Paclitaxel-induced apoptotic changes followed by time-lapse video microscopy in cell lines established from head and neck cancer. J Cancer Res Clin Oncol. 1996;122:214-218.
52. Raff MC. Social controls on cell survival and cell death. Nature. 1992;356: 397-400.
53. Aoshiba K, Rennard SI, Spurzem JR. Cell-matrix and cell-cell interactions modulate apoptosis of bronchial epithelial cells. Am J Physiol. 1997;72(Lung Cell Mol Physiol 16):L28-L37.
54. White E. Life, death and the pursuit of apoptosis. Genes Dev. 1996;10:1-15.
55. Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA. 1996;93:1-6.
56. Kerr JFR, Winterford CM, Harmon BV. Apoptosis: its significance in cancer and cancer research. Cancer. 1994;73:2013-2026.
57. Ongkeko W, Ferguson DJP, Harris AL, Norbury C. Inactivation of Cdc2 increases the level of apoptosis induced by DNA damage. J Cell Sci. 1995;108: 2897-2904.
58. Sherr CJ. Cancer cell cycles. Science. 1996;274:1672-1677.
59. King KL, Cidlowski JA. Cell cycle and apoptosis: common pathways to life and death. J Cell Biochem. 1995;58:175-180.
60. Wertz IE, Hanley MR. Diverse molecular provocation of programmed cell death. Trends Biochem Sci. 1996;21:359-364
61. Tang DG, Porter AT. Apoptosis: a current molecular analysis. Pathol Oncol Res. 1996;2:117-130.
62. Obeid LM, Hannun YA. Ceramide: a stress signal and mediator of growth suppression and apoptosis. J Cell Biochem. 1995;58:191-198.
63. Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997;326: 1-16.
64. Takahashi A, Earnshaw WC. ICE-related proteases in apoptosis. Curr Opin Genet Dev. 1996;6:50-55.
65. Barinaga M. Forging a path to cell death. Science. 1996;273:735-737.
66. Golstein P. Controlling cell death. Science. 1997;275:1081-1082.
67. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 1994;371:346-347.
68. Ankarcrona M, Zhivotovsky B, Holmstrom T, et al. Lamin and β-tubulin fragmentation precede chromatin degradation in glutamate-induced neuronal apoptosis. Neuroreport. 1996;7:2659-2664.
69. Migheli A, Cavalla P, Marino S, Schiffer D. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labelling of DNA strand breaks. J Neuropathol Exp Neurol. 1994;53:606-616.
70. Patel T, Gores GJ, Kaufmann SH. The role of proteases during apoptosis. FASEB J. 1996;10:587-597.
71. Kaufmann SH. Proteolytic cleavage during chemotherapy-induced apoptosis. Mol Med Today. 1996;2:298-303.
72. Jacobson MD, Burne JF, Raff MC. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J. 1994;13:1899-1910.
73. Schulze-Osthoff K, Walczak H, Droge W, Krammer PH. Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol. 1994;127:15-20.
74. Hoffman B, Liebermann DA. Molecular controls of apoptosis: differentiation/growth arrest primary response genes, proto-oncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene. 1994;9:1807-1812.
75. Preston GA, Lyon TT, Yin Y, et al. Induction of apoptosis by the c-Fos protein. Mo Cell Biol. 1996;16:211-218.
76. Evan GI, Harrington E, McCarthy N, Gilbert C, Benedict MA, Nunez G. Integrated control of cell proliferation and apoptosis by oncogenes. In: Thomas NSB, ed. Apoptosis and Cell Cycle Control in Cancer. Oxford, UK: BIOS Scientific Publishers Ltd; 1996:109-129.
77. Korsmeyer SJ. Bcl-2: a repressor of lymphocyte death. Immunol Today. 1992;13:285-288.
78. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 1988;335: 440-442.
79. Hengartner MO, Horvitz HR. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell. 1994;76: 665-676.
80. McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for the t(14;18). Nature. 1991;349:254-256.
81. Tsujimoto Y, Cossmann J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science. 1985;228:1440-1443.
82. Bissonnette RP, Echeverri F, Mahboudi A, Green DR. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature. 1992;359:552-554.
83. Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY. Expression of the bcl-2 protein is not specific for the 14;18 chromosomal translocation. Am J Pathol. 1990;137:225-232.
84. LeBrun DP, Warnke RA, Cleary ML. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol. 1993;142:743-753.
85. Pezzella F, Gatter K. What is the value of bcl-2 protein detection for histopathologists? Histopathology. 1995;26:89-93.
86. Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood. 1993;81:151-157.
87. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell. 1993;74: 609-619.
88. Boise LH, Gonzalez-Garcia M, Postema CE, et al. bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell. 1993; 74:597-608.
89. Hickman JA. Apoptosis and chemotherapy resistance. Eur J Cancer. 1996; 32A:921-926.
90. Kiefer MC, Brauer MJ, Powers VC, et al. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature. 1995;374:736-739.
91. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A. Epstein-Barr virus-coded BHFR1 protein, a viral homolog of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci USA. 1993;90: 8479-8483.
92. Rao L, White E. Bcl-2 and the ICE family of apoptotic regulators: making a connection. Curr Opin Genet Development. 1997;7:52-58.
93. Batsakis JG, El-Naggar AK. p53: fifteen years after discovery. Adv Anat Pathol. 1995;2:71-88.
94. Hall PA, Meek D, Lane DP. p53 - integrating the complexity. J Pathol. 1996;180:1-5. Editorial.
95. Levine AJ. p53, the cellular gatekeeper for growth and differentiation. Cell. 1997;88:323-331.
96. Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994; 9:1799-1805.
97. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell. 1992;70: 523-526.
98. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 1993;362:847-849.
99. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-independent apoptosis modulates the cytotoxicity of anti-cancer agents. Cell. 1993;74:957-967.
100. Lane DP. p53, guardian of the genome. Nature. 1992;358:15-16.
101. Hollstein M, Sidransky D, Vogelstein B, Harris C. p53 mutations in human cancers. Science. 1991;253:49-53.
102. Symmonds H, Krail L, Remington L, et al. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell. 1994;78:703-711.
103. Han J-W, Dionne CA, Kedersha NL, Goldmacher VS. p53 status affects the rate of the onset but not the overall extent of doxorubicin-induced cell death in Rat-1 fibroblasts constitutively expressing c-Myc. Cancer Res. 1997;57:176-182.
104. Sakamoro D, Eviner V, Elliott KJ, Showe L, White E, Prendergast GC. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene. 1995;11:2411-2418.
105. Yonehara S, Ishii AI, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med. 1989;169:1747-1756.
106. Trauth BC, Klas C, Peters AMJ, et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science. 1989;245:301-304.
107. Inoue M, Yano H, Kojiro M. Expression of Fas and anti-Fas-mediated apoptosis in human renal cell carcinoma. Int J Pathol. 1996;9:49-56.
108. Krammer PH. The tumor strikes back: new data on expression of the CD95(APO-1/FAS) receptor/ligand system may cause paradigm changes in our view on drug treatment and tumor immunology. Cell Death Differ. 1997;4:362-364.
109. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in the Fas antigen that mediates apoptosis. Nature. 1992;356:314-317.
110. Kerr JFR, Searle J. A suggested explanation for the paradoxically slow growth rate of basal cell carcinomas that contain numerous mitotic figures. J Pathol. 1972;107:41-44.
111. Merritt AJ, Potten CS, Kemp CJ, et al. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53 deficient mice. Cancer Res. 1994;54:614-617.
112. Clarke AR, Sphyris N, Harrison DJ. Apoptosis in vivo and in vitro: conflict or complementarity? Mol Med Today. 1996;2:189-191.
113. Del Vecchio MT, Leoncini L, Buerki K, et al. Diffuse centrocytic and/or centroblastic malignant non-Hodgkins lymhoma: comparison of mitotic and pyknotic (apoptotic) indices. Int J Cancer. 1991;45:38-43.
114. Arends MJ, McGregor AH, Wyllie AH. Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras and HPV oncogenes. Am J Pathol. 1994;144:1045-1057.
115. McMenamin ME, O Neill AJ, Gaffney EF. The extent of apoptosis in ovarian serous carcinoma in relationship to mitotic and proliferative indices, p53 expression and survival. J Clin Pathol (Mol Pathol). 1997;50:242-246.
116. Aihara M, Scardino PT, Truong LD, et al. The frequency of apoptosis correlates with prognosis of Gleason grade 3 adenocarcinoma of the prostate. Cancer. 1995;75:522-529.
117. O Neill AJ, Staunton MJ, Gaffney EF. Apoptosis occurs independently of bcl-2 and p53 over-expression in non-small cell lung carcinoma. Histopathology. 1996;29:45-50.
118. Quinn CM, Wright NA. The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic markers. J Pathol. 1990;160:93-102.
119. Steel GG. Cell loss as a factor in the growth rate of human tumours. Eur J Cancer. 1967;3:381-387.
120. Baserga R. Principles of molecular cell biology of cancer: the cell cycle. In: Devita VI Jr, Hellman S, Rosenberg SA, eds. Cancer, Principles & Practice of Oncology. 4th ed. Philadelphia, Pa: JB Lippincott: 1993:60-66.
121. Gonzalez MJ, Herrera FL. Cell loss and tumor growth revisited. Med Hypotheses. 1994;42:39-42.
122. Lipponen PK, Aaltomaa S. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J Pathol. 1994;173:333-339.
123. Spina D, Leoncini L, Megha T, et al. Stage-related differences of mitotic and apoptotic indices, and bcl-2 protein expression in diffusely growing nonHodgkin's lymphomas. Int J Cancer. 1996;68:436-440.
124. Kiberu SW, Pringle JH, Sobolewski, S, Murphy P, Lauder I. Correlation between apoptosis, proliferation and bcl-2 expression in malignant non-Hodgkin's lymphoma. J Clin Pathol (Clin Mol Pathol). 1996;49:M268-M272.
125. McGahon AJ, Cotter TG, Green DR. The abl oncogene family and apoptosis. Cell Death Differ. 1994;1:77-83.
126. Fernandes RS, Cotter TG. The repression of apoptosis by activated abl oncogenes in chronic myelogenous leukaemia. Leukemia. 1996;10(suppl2):S17-S21.
127. Du M, Singh N, Husseuin A, Isaacson PG, Pan L. Positive correlation between apoptosis and proliferative indices in gastrointestinal lymphomas of mucosa-associated lymphoid tissue (MALT). J Pathol. 1996;178:379-384.
128. Saegusa M, Kamata Y, Isono M, Okayasu I. Bcl-2 expression is correlated with a low apoptotic index and associated with progesterone receptor immunoreactivity in endometrial carcinomas. J Pathol. 1996;180:275-282.
129. Leek RD, Kaklamanis L, Pezzella F, Gatter KC, Harris AL. bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer. 1994;69:135-139.
130. Mustonen M, Raunio H, Paakko P, Soini Y. The extent of apoptosis is inversely associated with bcl-2 expression in premalignant and malignant breast lesions. Histopathology. 1997;31:347-354.
131. Sinicrope FA, Ruan SB, Cleary KR, et al. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 1995;55:237-241.
132. Chandler D, EI-Naggar AK, Brisbay S, Redline RW, McDonnell TJ. Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney: evidence for the contribution of bcl-2 expression to renal carcinogenesis. Hum Pathol. 1994;25:789-796.
133. Pezzella F, Turley H, Kuzu I, et al. bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med. 1993;329:690-694.
134. Ramani P, Lu Q-L. Expression of bcl-2 gene product in neuroblastoma. J Pathol. 1995;172:273-278.
135. Jiang S-X, Sato Y, Kuwao S, Tameya T. Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas. J Pathol. 1995;177:135-138.
136. y and bcl-2 protein in non-Hodgkin's lymphomas. Pathol Int. 1995; 45:422-429.
137. Soini Y, Paakko P. Extent of apoptosis in relation to p53 and bcl-2 expression in germ cell tumors. Hum Pathol. 1996;27:1221-1226.
138. Malcomson RDG, Clarke AR, Peter A, Coutts SB, Howie SEM, Harrison DJ. Apoptosis induced by y-irradiation but not CD4 ligation, of peripheral T lymphocytes in vivo is p53-dependent. J Pathol. 1997;181:166-171.
139. Evans CA, Owen PJ, Whetton AD, Dive C. Activation of the Abelson tyrosine kinase activity is associated with the suppression of apoptosis in haemopoietic cells. Cancer Res. 1993;53:1735-1738.
140. Daniel R, Wong PMC, Chung S-W. Isoform-specific functions of c-abl: type I is necessary for differentiation, and type IV is inhibitory to apoptosis. Cell Growth Differ. 1996;7:1141-1148.
141. O Neill AJ, Cotter TG, Russell JM, Gaffney EF. Abl expression in human fetal tissues, tumours and microvessels. J Pathol. 1997;183:325-329.
142. Wheeler TM, Rogers E, Aihara M, Scardino PT, Thompson TC. Apoptotic index as a biomarker in prostatic intraepithelial neoplasia (PIN) and prostate cancer. J Cell Biochem. 1994;19(suppl):202-207.
143. Aihara M, Truong LD, Dunn JK, Wheeler TM, Scardino PT, Thompson TC. Frequency of apoptotic bodies positively correlates with Gleason grade in prostate cancer. Hum Pathol. 1994;25:797-801.
144. McDonnell TJ, Troncoso P, Brisbay SM, et al. Expression of the protooncogene bcl-2 in the prostate and its association with the emergence of androgen-independent prostate cancer. Cancer Res. 1992;52:6940-6944.
145. Klein-Parker H, Warshawski L, Tron VA. Human melanocytes express bcl-2 protein. J Cutan Pathol. 1994;21:297-301.
146. Tron VA, Krajewski S, Klein-Parker H, Li G, Ho VC, Reed JC. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma. Am J Pathol. 1995;146:643-650.
147. Mooney EE, Ruis Peria JM, O Neill A, Sweeney EC. Apoptotic and mitotic indices in malignant melanoma and basal cell carcinoma. J Clin Pathol. 1995; 48:242-244.
148. van den Oord JJ, Vandeghinste N, De Ley M, De Wolf-Peeters C. Bcl-2 expression in human melanocytes and melanocytic tumours. Am J Pathol. 1994; 145:294-300.
149. Graeber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 1996;379:88-91.
150. Tsujitani S, Shirai H, Tatebe S, et al. Apoptotic cell death and its relationship to carcinogenesis in colorectal carcinoma. Cancer. 1996;77:1711-1716.
151. Fung K-M, Lee M-Y, Trojanowski JQ. Dynamics of cell proliferation and cell death during the emergence of primitive neuroectodermal tumors of the immature central nervous system in transgenic mice. Am J Pathol. 1995;146:1376-1387.
152. Pan H, Yin C, Van Dyke T. Apoptosis and cancer mechanisms. Cancer Surv. 1997;29:305-327.
153. Levine EL, Renehan A, Gossiel R, et al. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother Oncol. 1995;37:1-9.
154. Ellis PA, Smith IE, McCarthy K, Detre S, Salter J, Dowsett M. Preoperative chemotherapy induces apoptosis in early breast cancer. Lancet. 1997;349:849.
155. Ameisen JC. The origin of programmed cell death. Science. 1996;272: 1278-1279.